Company Overview

Khiron Life Sciences Corp. is a Canadian integrated medical cannabis company with its core operations in Colombia. Khiron combines leading international scientific expertise, agricultural advantages, and branded product market entrance experience to address the unmet medical needs in a market of over 620 million people in Latin America.

view more:

Khiron Life Sciences Hires Management Team to Lead Dixie Brands Joint Venture and Continue Market Expansion Strategy in Chile and Mexico

“We are excited to announce such a talented team will be joining Khiron as we continue to expand our market initiatives across various jurisdictions in Latin America.” #KHRN #KHRNF #DIXI #DXBR   Seasoned capital markets leader and cannabis authority John Cooke is appointed VP of Corporate Development Luis Chavas to manage corporate development strategy and guide regulatory affairs for

Khiron Expands Kuida® Retail Presence, Securing Partnerships With Fedco, Colombia’s Top Specialist Beauty Retailer And Linio, Latin America’s Largest Online E-Retailer

“We are happy to announce this retail distribution agreement with Khiron for the Kuida® brand.” #KHRN #KHRNF APRIL 03, 2019 Retail distribution with Fedco, the first and most established specialized beauty retailer in Colombia, with 22 stores expanding reach to 50% of Colombia’s territory Online distribution secured with Colombian e-retailer Linio, controlled by Grupo SACI

Khiron Life Sciences Enters Into $20 Million Bought Deal Equity Financing

#KHRN #KHRNF VANCOUVER, Feb. 6, 2019 /CNW/ – Khiron Life Sciences Corp. (“Khiron” or the “Company“) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC) is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp. and BMO Capital Markets as co-lead underwriters and joint bookrunners, and including Cormark Securities Inc. (together, the “Underwriters“) under which the

Khiron Life Sciences Signs Binding LOI to Acquire 100% of NettaGrowth, Securing the First Medical THC and CBD Cannabis Licence and Cultivation Capacity in Uruguay, and Entry to the Brazilian Market

TORONTO , Jan. 25, 2019  – Khiron Life Sciences Corp. (“Khiron” or the “Company“) (KHRN.V), (KHRNF), (Frankfurt:A2JMZC), an integrated medical cannabis company with its core operations in Latin America , announced today that the Company has entered into a binding letter agreement dated January 24, 2019 to acquire 100% of NettaGrowth International Inc. (“NettaGro“), an arm’s